146 related articles for article (PubMed ID: 21288675)
1. Hepatocellular carcinoma with marginal superparamagnetic iron oxide uptake on T2*-weighted magnetic resonance imaging: histopathologic correlation.
Ishigami K; Tajima T; Fujita N; Nishie A; Asayama Y; Kakihara D; Nakayama T; Okamoto D; Taketomi A; Shirabe K; Honda H
Eur J Radiol; 2011 Dec; 80(3):e293-8. PubMed ID: 21288675
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
4. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.
Kim SH; Lee WJ; Lim HK; Park CK
Korean J Radiol; 2009; 10(2):112-20. PubMed ID: 19270856
[TBL] [Abstract][Full Text] [Related]
5. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
6. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
[TBL] [Abstract][Full Text] [Related]
8. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
[TBL] [Abstract][Full Text] [Related]
9. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatocellular carcinoma with ferucarbotran (resovist)-enhanced breath-hold MR imaging: feasibility of 10 minute-delayed images.
Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
Magn Reson Med Sci; 2008; 7(3):123-30. PubMed ID: 18827455
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
14. Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis.
Yoon MA; Kim SH; Park HS; Lee DH; Lee JY; Han JK; Choi BI
Invest Radiol; 2009 Oct; 44(10):641-9. PubMed ID: 19724237
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
16. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
17. Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases.
Teerasamit W; Saiviroonporn P; Pongpaibul A; Korpraphong P
J Med Assoc Thai; 2014 May; 97(5):540-7. PubMed ID: 25065095
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis.
Li YW; Chen ZG; Wang JC; Zhang ZM
World J Gastroenterol; 2015 Apr; 21(14):4334-44. PubMed ID: 25892885
[TBL] [Abstract][Full Text] [Related]
19. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
Macarini L; Marini S; Murrone M; Ettorre GC
Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between SPIO-enhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma].
Zhang XH; Liang BL; Huang SQ
Ai Zheng; 2003 Jul; 22(7):734-8. PubMed ID: 12866966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
